300677 英科医疗
2026/06 - 中期
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入6,909,02340.61%9,925,8199,523,3176,918,7246,613,814
减:营业总成本5,605,23127.18%9,433,9558,106,2026,753,5606,051,332
    其中:营业成本4,296,17915.40%7,531,5567,272,3485,971,0235,745,717
               财务费用459,25418,314.56%416,528(436,625)(306,436)(627,253)
               资产减值损失34,399-455.39%(31,422)(109,053)(5,349)(44,038)
公允价值变动收益(299,266)-231.00%318,499279,767175,56759,670
投资收益43,200-15.39%379,72163,17787,44683,271
    其中:对联营企业和合营企业的投资收益------------
营业利润1,096,21634.27%1,230,1711,676,824438,990707,184
利润总额1,072,17932.04%1,229,7401,608,918442,818704,414
减:所得税费用167,87596.54%182,553117,22954,75365,071
净利润904,30424.45%1,047,1871,491,689388,065639,343
减:非控股权益66,963313.73%36,48726,2135,06710,273
股东净利润837,34117.86%1,010,7001,465,476382,998629,070

市场价值指针
每股收益 (元) *1.31016.96%1.5802.2600.5800.950
每股派息 (元) *0.100100.00%0.1500.1500.0800.100
每股净资产 (元) *29.0194.12%27.86126.93324.43423.965
审计意见 #--标准无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容